MY ACCOUNT | NEWSLETTER |

CORRECTING and REPLACING Petwealth Emerges from Stealth with $1.7 Million in Funding, Landmark Partnerships, and a Mission to Become the Functional Health Platform for Pets


Petwealth, the at-home PCR diagnostics and AI-powered health intelligence platform for dogs and cats, today announced its emergence from stealth mode with $1.7 million raised to date and is currently raising its pre-seed round. The announcement comes as the U.S. pet industry has experienced a surge in growth over recent years, with Americans now spending more than $200 billion annually on their pets, a figure that reflects a fundamental shift in how people think about animal care. Petwealth is purpose-built to meet that moment, bringing clinical-grade diagnostics to a market that has long lacked them. Alongside this milestone, Petwealth unveiled two strategic partnerships: an exclusive diagnostic partnership with Kennel Connection and a telehealth integration with Pawp.

Founded in 2025 by Angelo Palivos following the sudden passing of his dog Mochi, Petwealth provides pets with what has been available for humans: making clinical-grade health data proactive, personalized, and accessible before symptoms appear. Co-founder Zoë Barry joined shortly after the founding, shaping the company's commercial strategy and vision for an industry-wide impact.

“We are not just building a product. We are building the diagnostic infrastructure that the entire pet health industry has been missing. The partnerships we are announcing today are proof that the industry sees it too.”

- Angelo Palivos, Co-CEO and Co-Founder, Petwealth

The Platform

Petwealth operates an industry-best molecular laboratory processing thousands of tests per day. Its flagship product, The Petwealth Pack ($399), combines fecal, oral, and respiratory PCR panels into a single at-home kit with AI-powered health insights delivered in 24 to 48 hours. Individual panels are available at $175 each. The platform serves pet parents, veterinarians, and pet care businesses alike.

Kennel Connection: Exclusive Diagnostic Partner

Petwealth is the exclusive diagnostic partner for Kennel Connection, the leading pet care management software powering more than 5,500 locations across the U.S. The integration brings clinical-grade PCR screening directly into the daily operations of daycares, boarding facilities, groomers, and pet hotels.

“As the Pet Care Industry continues to grow, and more families cherish the lives of their fur babies, I believe it's our job to bring the most innovative and feature rich technology to the industry at large. After hearing Petwealth's story and seeing how this innovative Pet Health Technology is already saving pets lives, it was a no brainer for Kennel Connection to partner with Petwealth.”

- Jeff Brodsly, Owner and CEO, Kennel Connection

Pawp: Telehealth Partner

Through its partnership with Pawp, every Petwealth report connects pet parents to a licensed veterinarian on demand, 24/7, ensuring no one is left to interpret clinical results alone.

“At Pawp, we believe every pet parent deserves access to a veterinarian when it matters most. Partnering with Petwealth means that the moment a parent receives diagnostic results, they can connect with a licensed vet to understand what those results mean and what to do next. That closes a real gap in pet care.”

- Marc Atiyeh, CEO and Co-Founder, Pawp

About Petwealth

Petwealth is a Miami-based pet health diagnostics company founded in 2025 by Angelo Palivos and Zoë Barry. Born from the loss of Palivos' dog Mochi, the company delivers gold-standard PCR testing and AI-powered health insights for dogs and cats, screening 100+ markers across fecal, oral, and respiratory health with results in 24 to 48 hours. Petwealth's mission is to make proactive pet health simple, accessible, and trusted.


Source: www.petwealth.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

40 Under 40: Dr. Cassi Fleming

Like0
Dislike0

Unlocking the potential of ICT innovation in veterinary healthcare: The pathway to improve practices and business model

Like0
Dislike0

Canine papillomavirus: status of diagnostic methods and vaccine innovations

Like0
Dislike0

Analysing innovations among cattle smallholders to evaluate the adequacy of breeding programs

Like0
Dislike0

Penn Vet Announces Interim Leadership for the Department of Clinical Sciences and Advanced Medicine, and Ryan Hospital

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top